NCT06893250View on ClinicalTrials.gov

Orthobiologic Treatment for Knee Osteoarthritis

PHASE2/PHASE3Enrolling by invitationINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

September 23, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2027

Conditions
Osteoarthritis Knee
Interventions
BIOLOGICAL

PRP injection

Platelet rich plasma, blood from the patient that is centrifuged.

BIOLOGICAL

ADSTEM Inj. (Adult human mesenchymal stem cells)

Adipose tissue stem cells, from abdominal fat.

BIOLOGICAL

Injection

PRP + adipose tissue stem cells

BIOLOGICAL

Saline (NaCl 0,9 %) (placebo)

Sterile saline injection.

Trial Locations (1)

9038

University Hospital in Northern Norway, Tromsø

All Listed Sponsors
lead

University Hospital of North Norway

OTHER